Bio Essence Corp 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-108357
- Form type
- 10-Q
- CIK
- 0001723059
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723059/000121390025108357/ea0264490-10q_bioessen.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bio Essence Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $418,112 | - | - |
| Cost Of Revenue | $133,120 | - | - |
| Gross Profit | $284,992 | - | - |
| Operating Income | $-129,616 | - | - |
| Net Income | $-132,890 | - | - |
| Cash And Equivalents | $28,741 | - | - |
| Total Assets | $184,534 | - | - |
| Total Liabilities | $3.3M | - | - |
| Shareholders Equity | $-3.1M | - | - |
| Operating Cash Flow | $328,701 | - | - |